Compare the immunogenicity, reactogenicity % safety of 2 different formulations of GSK Biologicals’ live attenuated human rotavirus (HRV) vaccine given as a two-dose primary vaccination in healthy infants previously uninfected with HRV
Rotavirus Vaccine
Infections, Rotavirus
Phase 2
An annotated case report form is not available for this study. A blank case report form will be provided.
January 2014